You have booked the consultation. Or you have already taken your first weekly dose. And now the question that sits in the back of your mind is the one [...]
Semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1 RA), originally developed to treat type 2 diabetes, has emerged as a promising agent fo [...]